journal article·2023-04-05

One-Pot Rapid Synthesis of Cu2+-Doped GOD@MOF to Amplify the Antitumor Efficacy of Chemodynamic Therapy

Qing Li, Jiantao Yu, Li Lin, Yulin Zhu, Zixiang Wei, Feiyan Wan, Xindan Zhang, Feng He, Leilei Tian

ACS Applied Materials & Interfaces· Volume 15· Issue 13
Publisher page

Abstract

Chemodynamic therapy (CDT) relies on the transformation of intracellular hydrogen peroxide (H 2 O 2 ) to hydroxyl radicals (·OH) with higher toxicity under the catalysis of Fenton/Fenton-like reagents, which amplifies the oxidative stress and induces significant cellular apoptosis. However, the CDT efficacy is generally limited by the overexpressed GSH and insufficient endogenous H 2 O 2 in tumors. Co-delivery of Cu 2+ and glucose oxidase (GOD) can lead to a Cu 2+ /Cu + circulation to realize GSH depletion and amplify the Fenton-like reaction. pH-responsive metal–organic frameworks (MOFs) are the optical choice to deliver Fenton/Fenton-like ions to tumors. However, considering that the aqueous condition is requisite for GOD encapsulation, it is challenging to abundantly dope Cu 2+ in ZIF-8 MOF nanoparticles in aqueous conditions due to the ease of precipitation and enlarged crystal size. In this work, a robust one-pot biomimetic mineralization method using excessive ligand precursors in aqueous conditions is developed to synthesize GOD@Cu-ZIF-8. Copper ions abundantly doped to the GOD@Cu-ZIF-8 can eliminate GSH to produce Cu +, which is further proceeded to the Fenton-like reaction in the presence of GOD-catalyzed H 2 O 2 . Through breaking the tumor microenvironment homeostasis and producing an enhanced CDT effect, the promising antitumor capability of GOD@Cu-ZIF-8 was evidenced by the experiments both in vitro and in vivo .
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Metal-Organic Frameworks: Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Materials Science and Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China

Department of Chemistry, Shenzhen Grubbs Institute, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China

Funding

Science, Technology and Innovation Commission of Shenzhen Municipality · National Natural Science Foundation of China

References (44)

Show source-provided references
1. 10.1021/acs.chemrev.0c0097710.1021/acs.chemrev.0c00977 ↗
2. 10.1002/anie.20180566410.1002/anie.201805664 ↗
3. 10.1002/adma.20210422310.1002/adma.202104223 ↗
4. 10.1021/acsnano.8b0763510.1021/acsnano.8b07635 ↗
5. 10.1039/D1MA00646K10.1039/D1MA00646K ↗
6. 10.1002/adma.20200689210.1002/adma.202006892 ↗
7. 10.1002/anie.20171202710.1002/anie.201712027 ↗
8. 10.1021/acsnano.8b0938710.1021/acsnano.8b09387 ↗
9. 10.1016/j.biomaterials.2019.04.02310.1016/j.biomaterials.2019.04.023 ↗
10. 10.1053/rmed.2000.082510.1053/rmed.2000.0825 ↗
11. 10.1021/jacs.7b0555910.1021/jacs.7b05559 ↗
12. 10.1021/acsnano.8b0504210.1021/acsnano.8b05042 ↗
13. 10.1021/acs.nanolett.8b0272010.1021/acs.nanolett.8b02720 ↗
14. 10.1021/acsnano.8b0908210.1021/acsnano.8b09082 ↗
15. 10.1002/adma.20180832510.1002/adma.201808325 ↗
16. 10.1007/s40843-019-1226-810.1007/s40843-019-1226-8 ↗
17. 10.1021/jacs.8b0871410.1021/jacs.8b08714 ↗
18. 10.1038/s41467-017-00424-810.1038/s41467-017-00424-8 ↗
19. 10.1002/adma.20160613410.1002/adma.201606134 ↗
20. Horcajada P. · Chem. Rev. · 2012 · 112 · 123210.1021/cr200256v ↗
21. 10.1021/acsami.7b1652210.1021/acsami.7b16522 ↗
22. 10.1021/jacs.5b1172010.1021/jacs.5b11720 ↗
23. 10.1021/acsomega.9b0361510.1021/acsomega.9b03615 ↗
24. 10.1039/D0RA02943B10.1039/D0RA02943B ↗
25. 10.1021/ja501958u10.1021/ja501958u ↗
26. 10.1002/asia.20210074010.1002/asia.202100740 ↗
27. 10.3390/ma1402031010.3390/ma14020310 ↗
28. 10.1039/C8CS00337H10.1039/C8CS00337H ↗
29. 10.1039/C4TA02984D10.1039/C4TA02984D ↗
30. 10.1126/science.aao340310.1126/science.aao3403 ↗
31. 10.1016/j.jssc.2020.12121910.1016/j.jssc.2020.121219 ↗
32. 10.1016/j.ica.2020.11941210.1016/j.ica.2020.119412 ↗
33. 10.1021/acsami.0c2291010.1021/acsami.0c22910 ↗
34. 10.1039/c2ce26847g10.1039/c2ce26847g ↗
35. 10.1021/acsami.1c1459810.1021/acsami.1c14598 ↗
36. 10.1021/acsami.2c0055210.1021/acsami.2c00552 ↗
37. 10.1021/acsami.9b1068510.1021/acsami.9b10685 ↗
38. Yu J. · Adv Sci. · 2021 · 8 · 210146710.1002/advs.202101467 ↗
39. 10.1039/C5TA09464J10.1039/C5TA09464J ↗
40. 10.1016/j.cplett.2013.04.00710.1016/j.cplett.2013.04.007 ↗
41. 10.1021/ja403635b10.1021/ja403635b ↗
42. 10.1016/j.chempr.2019.05.01310.1016/j.chempr.2019.05.013 ↗
43. 10.1021/acsnano.8b0520010.1021/acsnano.8b05200 ↗
44. 10.1016/j.bioadv.2022.21326810.1016/j.bioadv.2022.213268 ↗